Blood Irradiator Market - Size, Share, Outlook, and Forecast till 2026

Blood irradiation is a therapy in which blood is exposed to low level red light for therapeutic purposes. Blood used in transfusion is required to be free from infections and bacteria, which is made possible with the help of blood irradiators. Hospitals run the blood through this machine, which uses radioactive materials as a sterilizer.

Doctors make use of radioactive cesium chloride salt, which contains the isotope cesium-137, to irradiate blood before it is transfused to patients. The radiation is aimed at preventing transfusion associated graft-versus-host disease (TA-GVHD), a rare and nearly always fatal complication to blood transfusions, in which transfused white blood cells attack the recipient’s tissue. This treatment helps to save lives. This in turn, is increasing the demand for these irradiators, in turn driving growth of the blood irradiators market.

Ultraviolet Blood Irradiation (UBI) exposes blood to light to heighten the body's immune response and to kill infections. This helps absorb five times as much photonic energy as do red and white blood cells. This heightened efficiency in turn, is boosting growth of the blood irradiators market.

However, the radioactive material used in these blood irradiators, cesium-137, has high susceptibility to be stolen by terrorists and used to build radioactive ‘dirty bombs’. Cesium-137 also can cause harm if misused or misplaced by accident. The interactive also shows steps countries are taking to replace cesium-137 blood irradiators with safe and effective alternative technology. This poses as a major factor hindering growth of the blood irradiators market.

These machines are self-contained and easy to operate, prevents transfusion associated graft versus host disease, they are located at most major hospitals and Cs-137 is majorly used.

In Goiana, Brazil, four people died and hundreds were hospitalized after a capsule containing cesium-137 ruptured, resulting in one of the worst radiological disasters in history. The source was not a blood irradiator, but the incident highlights the risk this isotope poses. Mass contamination resulted in the demolition of many buildings, and roughly 112,000 people sought medical attention out of fear they might have been exposed to radiation, overwhelming the healthcare system, and preventing people who needed other medical attention from receiving it.

Report includes chapters which deeply display the following deliverable about industry:

• Blood Irradiator Market Research Objective and Assumption
• Blood Irradiator Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM)
• Blood Irradiator Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Blood Irradiator Market, By Regions
• Blood Irradiator Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Blood Irradiator Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors.
• Blood Irradiator Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change.
• Blood Irradiator Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion